how to manage glp-1 side effects GI Adverse of Glucagon-Like Peptide-1 Receptor Agonists GLP-1 Medication Side Effects: What's

Podocyte-specific Nlrp3 inflammasome activation promotes diabetic kidney disease

In laboratory settings, the combination has been studied for its dual interaction with GHRH and ghrelin pathways, with investigations focusing on receptor binding, signaling, and the modulation of hormone dynamics

If constipation-predominant IBS worsens significantly or diarrhea-predominant IBS shifts to severe constipation, medication adjustment may be necessary

The daily oral dose depends on age and weight: from 0 to 2 years, 150 mg per kg of body weight is recommended, from 2 to 6 years, 100 mg per kg, from 6 to 12 years, 75 mg per kg, over 12 years and in adults, 2 - 4 grams according to the severity of the pathology and the doctor's judgment